Showing results (51-60 of 140) with videos related to
Sort By:
Pageof 14
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 16, 2019
Involvement of SAPK/JNK Signaling Pathway in Copper Enhanced Zinc-Induced Neuronal Cell DeathKen-Ichiro Tanaka, Mikako Shimoda, Misato Kasai, et al.Scientific Reports|February 17, 2017
Preventive Effects of Carnosine on Lipopolysaccharide-induced Lung InjuryKen-Ichiro Tanaka, Toshifumi Sugizaki, Yuki Kanda, et al.European Journal of Pharmacology|April 8, 2014
Fentanyl produces an anti-hyperalgesic effect through the suppression of sodium channels in mice with painful diabetic neuropathyKen-ichiro Tanaka, Yuki Nakanishi, Shyota Sekino, et al.Biochemical and Biophysical Research Communications|June 14, 2014
Active vitamin D possesses beneficial effects on the interaction between muscle and boneKen-ichiro Tanaka, Ippei Kanazawa, Toru Yamaguchi, et al.Life Sciences|November 25, 2021
Novel pharmacological effects of lecithinized superoxide dismutase on ischemia/reperfusion injury in the kidneys of miceKen-Ichiro Tanaka, Mikako Shimoda, Maho Kubota, et al.Biological & Pharmaceutical Bulletin|August 12, 2004
Cytotoxic synergy between indomethacin and hydrochloric acid in gastric mucosal cellsKen-Ichiro Tanaka, Wataru Tomisato, Shinji Tsutsumi, et al.Internal Medicine (Tokyo, Japan)|July 3, 2015
An Open-label Longitudinal Study on the Efficacy of Switching from Insulin Glargine or Detemir to Degludec in Type 2 Diabetes MellitusIppei Kanazawa, Masakazu Notsu, Ken-ichiro Tanaka, et al.Plos One|October 14, 2020
Carnosine suppresses neuronal cell death and inflammation induced by 6-hydroxydopamine in an in vitro model of Parkinson's diseaseMaho Kubota, Nahoko Kobayashi, Toshifumi Sugizaki, et al.Biochemical and Biophysical Research Communications|January 17, 2012
FAM5C is a soluble osteoblast differentiation factor linking muscle to boneKen-ichiro Tanaka, Erika Matsumoto, Yoshiko Higashimaki, et al.European Journal of Pharmacology|December 23, 2008
Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitisKen-Ichiro Tanaka, Shintaro Suemasu, Tomoaki Ishihara, et al.Pageof 14